These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen. Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897 [TBL] [Abstract][Full Text] [Related]
4. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants? Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157 [TBL] [Abstract][Full Text] [Related]
5. Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response. Sawyer WT; Poe TE; Canaday BR; Weiner JS; Williams DM; Webb CE; Ellison MJ Clin Pharm; 1985; 4(4):440-6. PubMed ID: 3899472 [TBL] [Abstract][Full Text] [Related]
6. APOE genotype makes a small contribution to warfarin dose requirements. Sconce EA; Daly AK; Khan TI; Wynne HA; Kamali F Pharmacogenet Genomics; 2006 Aug; 16(8):609-11. PubMed ID: 16847429 [TBL] [Abstract][Full Text] [Related]
7. Predicting warfarin maintenance dosage based on initial response. Miller DR; Brown MA Am J Hosp Pharm; 1979 Oct; 36(10):1351-5. PubMed ID: 507078 [TBL] [Abstract][Full Text] [Related]
8. CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy. Peyvandi F; Spreafico M; Siboni SM; Moia M; Mannucci PM Clin Pharmacol Ther; 2004 Mar; 75(3):198-203. PubMed ID: 15001971 [TBL] [Abstract][Full Text] [Related]
9. Self-management of anticoagulation. Levi M Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):979-85. PubMed ID: 18666848 [TBL] [Abstract][Full Text] [Related]
10. Clinical impact of temporary therapy interruptions on anticoagulation control in patients treated with warfarin. Boros ML; Rybarczyk AM; Gallegos PJ; Zimmerman JP Am J Ther; 2013; 20(3):267-74. PubMed ID: 23011173 [TBL] [Abstract][Full Text] [Related]
11. A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. Gardiner C; Williams K; Longair I; Mackie IJ; Machin SJ; Cohen H Br J Haematol; 2006 Mar; 132(5):598-603. PubMed ID: 16445833 [TBL] [Abstract][Full Text] [Related]
15. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation. Koefoed BG; Feddersen C; Gulløv AL; Petersen P Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390 [TBL] [Abstract][Full Text] [Related]
16. Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population. Buchanan-Leel B; Levetan BN; Lombard CJ; Commerford PJ J Heart Valve Dis; 2002 Jul; 11(4):583-92; discussion 593. PubMed ID: 12150309 [TBL] [Abstract][Full Text] [Related]
17. Intravenous warfarin as an alternative for anticoagulation. Gellatly RM Pharmacotherapy; 2007 Jun; 27(6):933-5. PubMed ID: 17542775 [TBL] [Abstract][Full Text] [Related]
18. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment. D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163 [TBL] [Abstract][Full Text] [Related]
19. Warfarin sensitivity after mechanical heart valve replacement. Rose JP; Rihn TL; Long SF Pharmacotherapy; 1998; 18(4):856-9. PubMed ID: 9692661 [TBL] [Abstract][Full Text] [Related]
20. Warfarin maintenance dose adjustment with indirect pharmacodynamic model in rats. Cao YG; Liu XQ; Chen YC; Hao K; Wang GJ Eur J Pharm Sci; 2007 Feb; 30(2):175-80. PubMed ID: 17169538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]